Brought to you by 
Tularik and Japan Tobacco sign their third alliance
01 Apr 2003
Executive Summary
Tularik (small-molecule drugs based on gene regulation) is forming a wholly owned subsidiary called Tularik Pharmaceutical Co. that will conduct the research part of a broad alliance with Japan Tobacco to discover and develop treatments for metabolic diseases.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com